DeNovaMed is an early-stage pharmaceutical company specializing in new therapeutic approaches to combat bacterial infections. The company approached Axxiem for brand consulting and the development of a marketing website to establish the organization's web presence.
Axxiem developed a logo for DeNovaMed and designed visually consistent website based on its aesthetic. The project included development a compelling homepage slideshow, a custom product pipeline graphic, and migration of the company's email system to Axxiem's emali services.
The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The company was looking for a clean, clear web presence that communicated their scope of their organization and its work worldwide.
Axxiem developed and delivered a custom, CMS-driven website for The Medicines Company that clearly highlights their work in the fields of acute and intensive care medicine. The project also included integration of the company's Investor Relations content, driven by EDGAR Online. Axxiem also worked with The Medicines Company to update the site on a tight timeframe in response to branding changes within the organization.
Thank you very much for the timely and professional response to our urgent request!
Catalyst Pharmaceutical Partners, Inc., is a specialty pharmaceutical company focused on in-licensing, developing and commercializing novel prescription drugs to treat rare (orphan) neurological diseases and disorders. Catalyst is an established public company that was looking for website redesign while preserving existing branding and corporate identity. The desire for a new website also coincided with a shift in the companys target therapeutic areas, requiring adjustments to overall messaging and content.
Consulting with the firm to fully understand their new directions, Axxiem designed a new site keeping a solid connection with the brand while representing some very new directions for the firm. The new site has a fresh and contemporary feel, and uses warm imagery to welcome the visitors. The project also included integration with Investor Relations services provided by Shareholder.com.
Transparency Life Sciences is the world’s first drug development company based on open innovation, with the goal of developing medicines for significant unmet medical needs by acquiring promising drug compounds, designing studies via crowdsourced methods, and conducting those clinical studies. Axxiem was tasked with selecting and intergrating the appropriate technologies required to achieve the project's unique objectives.
Axxiem developed and delivered a fully customized, Drupal-based platfrom integrating Google Docs API, single-signon, Webform surveys and other usability features. A robust admin panel allows for total management of all content, users, community features and statistical data.